BUPA increases cancer cover, UK

In an industry for the first time, has plans to improve the quality of his cancer coverage by corporate health insurance schemes, BUPA, the leading international group of healthcare sales no longer function as a whole cost or time-limits for the treatment of cancer announced.

2005 And 2006 due to the introduction of new medicines increased cancer treatment costs sharply. In response to the concerns that caused this about rising costs, the health insurance market developed financial benefit of caps and restrict deadlines to financial burden for client companies.

However, experience has shown that these limits mean that patients who claim on their policy vulnerable to critical points in their treatment can be kept.

When employees reach their benefit ceiling, they are the ability to change their treatment of the middle of the stream. The different costs of cancer drugs makes it very difficult for patients to make informed decisions about their treatment path and its likely costs, at the time of diagnosis.

Dr Natalie-Jane Macdonald, General Manager, BUPA health and well-being explains: "we work closely with our customers to help they offer their employees with the best quality healthcare to a sustainable, affordable price, and this remains a priority for us." "We have better control fairer way health costs, without the experience and results of patients developed at a difficult time in their lives."

In the year 2010 BUPA spent 18 m pounds sterling on drugs, which are widely available elsewhere and it routinely fund cancer treatments, by the European Medicines Agency. BUPA Decides also prompt for experimental drugs, where appropriate, clinical pay.

Notes

BUPA started corporate in December 2009, select an option to apply a maximum annual benefit. Based on this experience, BUPA recognises that they may offer a poor customer experience.

Faced with the reality of what they mean in practice companies that often logged on apply them you want to. BUPA currently has a very small number of clients to implement these restrictions of their corporate policies and options for managing their costs for the healthcare it works with them.

Source:
BUPA group